First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.075 USD 1.42% Market Closed
Updated: Apr 29, 2024
ADAP
/
Cash Flow Statement
/
Cash from Financing Activities

Adaptimmune Therapeutics PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adaptimmune Therapeutics PLC
Cash from Financing Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Cash from Financing Activities
$880k
CAGR 3-Years
-86%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Financing Activities
$21.1m
CAGR 3-Years
149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Financing Activities
-$883k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Financing Activities
$250m
CAGR 3-Years
58%
CAGR 5-Years
58%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Financing Activities
£34.3m
CAGR 3-Years
-33%
CAGR 5-Years
221%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Financing Activities
-£20.5m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Adaptimmune Therapeutics PLC's Cash from Financing Activities?
Cash from Financing Activities
880k USD

Based on the financial report for Dec 31, 2023, Adaptimmune Therapeutics PLC's Cash from Financing Activities amounts to 880k USD.

What is Adaptimmune Therapeutics PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-61%

Over the last year, the Cash from Financing Activities growth was -93%. The average annual Cash from Financing Activities growth rates for Adaptimmune Therapeutics PLC have been -86% over the past three years , -61% over the past five years .

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.